Literature DB >> 31603922

A reconnaissance survey of farmers' awareness of hypomagnesaemic tetany in UK cattle and sheep farms.

Diriba B Kumssa1, Beth Penrose2, Peter A Bone3, J Alan Lovatt4, Martin R Broadley1, Nigel R Kendall5, E Louise Ander6.   

Abstract

Hypomagnesaemic tetany (HypoMgT) in ruminants is a physiological disorder caused by inadequate intake or impaired absorption of magnesium (Mg) in the gut. If it is not detected and treated in time, HypoMgT can cause the death of the affected animal. A semi-structured questionnaire survey was conducted from July 2016-2017 to assess farmers' awareness of HypoMgT in cattle and sheep in the UK. The questionnaire was distributed to farmers at farm business events and agricultural shows, and through a collaborative group of independent veterinary practices to their clients. Farmers were asked about (i) the incidence of presumed HypoMgT (PHT); (ii) their strategies to treat or prevent HypoMgT; (iii) mineral tests on animals, forage and soil, and (iv) farm enterprise type. A total of 285 responses were received from 82 cattle, 157 mixed cattle and sheep, and 46 sheep farmers, of whom 39% reported HypoMgT in their livestock, affecting 1-30 animals. Treatment and/or prevention against HypoMgT was reported by 96% respondents with PHT and 79% of those without. Mineral tests on animal, forage, and soil was conducted by 24%, 53%, and 66% of the respondents, respectively, regardless of PHT. There was a highly significant association between the use of interventions to tackle HypoMgT and the incidence of PHT (p < 0.01). The top three treatment/prevention strategies used were reported as being free access supplementation (149), in feed supplementation (59) and direct to animal treatments (drenches, boluses and injections) (45) although these did vary by farm type. Although some (9) reported using Mg-lime, no other pasture management interventions were reported (e.g., Mg-fertilisation or sward composition). Generally, the results indicate that UK farmers are aware of the risks of HypoMgT. A more integrated soil-forage-animal assessment may improve the effectiveness of tackling HypoMgT and help highlight the root causes of the problem.

Entities:  

Year:  2019        PMID: 31603922      PMCID: PMC6788701          DOI: 10.1371/journal.pone.0223868

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Hypomagnesaemic tetany (HypoMgT), also known as grass tetany or grass staggers is caused by either an inadequate magnesium (Mg) supply to ruminants or reduced absorption of Mg in the rumen [1]. Signs of HypoMgT can include excitability, grinding of the teeth, salivation, a lack of coordination of muscle movement (e.g., a staggering gait), lying down or muscle spasms, and can lead to death within hours [2, 3]. Hypomagnesaemia can create a safety issue for farm workers, a reduction in milk fat content [4], a higher susceptibility to hypocalcaemia [5] and dark cutting in sheep [6] and cattle carcass [7]. Historically, HypoMgT has been an issue in temperate regions around the world. A study in the 1960s of 477 New Zealand dairy farms found rates of HypoMgT to be between 0.2 and 3.9% [8] and deaths alone from HypoMgT were estimated to cost US$70 million per year in the 1970s [9]. A study in the 1990s in Northern Ireland found deficient blood serum magnesium levels (<0.6 mmol L-1) in 2% of dairy cows tested (n = 3626 cows, 377 herds) and 7.3% of beef suckler cows (n = 6664 cows, 772 herds; [10]. In a UK study, 19% of dairy farms (n = 23) and 23% of suckler beef farms (n = 89) had presumed HypoMgT (PHT) in 1995 [11]. More recent data are difficult to come by, however, estimates for the temperate regions of Australia are that 60% of cattle holdings are affected by HypoMgT, and the costs of prevention, treatment of HypoMgT and the effect on cattle production are estimated to be around AUD$23 million [12]. In UK grazing ruminants, hypomagnesaemia-related conditions have been reported to affect 1–4% of cows, rising to 20–30% within individual herds [13]. To the authors’ knowledge, there are no recent estimates of the prevalence of HypoMgT in UK livestock systems. Preventative measures to reduce the risk of HypoMgT include: (i) direct to animal strategies such as administering Mg-containing bullets or boluses, and delivering Mg via drenches; (ii) in-feed strategies where Mg is included in a concentrate or total mixed ration, usually as part of a mineral premix; (iii) adding Mg to the drinking water; (iv) providing free-access Mg-containing salt licks and buckets; and (v) soil or plant-based strategies. Soil and plant-based strategies in particular are wide-ranging, and can include foliar and soil-based application of Mg fertilisers, dusting pasture with Mg-containing minerals [1, 14], application of K fertilisers during winter, applying nitrogenous fertiliser with Mg if nitrogen is applied to pasture before grazing, grazing on permanent pastures in spring, and cutting and removing grass before grazing on paddocks with a grass tetany history [15]. Direct treatment of HypoMgT is usually via subcutaneous injection of magnesium sulphate [14] or magnesium hypophosphate often alongside calcium borogluconate. A 1991 survey in Northern Ireland found that 19.8% of dairy (n = 263 farmers) and 20.9% of (n = 522 farmers) beef suckler farmers surveyed reported that they did not use any form of Mg supplementation [10]. Roderick et al. [11] reported a 19% and 23% incidence of grass staggers in dairy and beef suckler herds, respectively under organic farming systems in the UK. To the authors’ knowledge, there are no up-to-date data available regarding the extent to which preventative or treatment measures are currently being used in the UK. The purpose of this study was to: (i) provide a snapshot of the extent of Mg deficiencies in UK dairy, beef and sheep enterprises; (ii) record the measures UK livestock producers were taking to treat or prevent HypoMgT in their herds or flocks; (iii) determine how aware UK livestock producers were of Mg concentrations in their soil, pasture and livestock; and (iv) understand any associations between the incidence of Mg deficiencies, awareness of their vulnerability to Mg deficiencies, and the strategies they were employing to reduce the risk of HypoMgT.

Materials and methods

A semi-structured questionnaire (see S1 Information) survey was used to collect data on the prevalence of HypoMgT in UK cattle and sheep farms (Fig 1). Ethical approval was sought before conducting the survey (Ethical approval number 1814160621, School of Veterinary Medicine and Science Ethical review panel, University of Nottingham). Data collection was carried out either online using KoBoToolBox or by distributing paper questionnaires to farmers at industry events including AgriScot, and the Royal Welsh Summer and Winter shows, and Agriculture and Horticulture Development Board (AHDB) farm knowledge exchange events between July 2016–2017. The questionnaires were also distributed to clients of veterinary practices within XLVets, a collaborative group of independent veterinary practices in the UK. Prior to completing the survey, farmers were presented with information sheet (see S1 Information) about the objective of the survey and how data collected during this survey was to be used. Where paper questionnaires were handed to respondents at farm events or via their vet, responses were received via postal mail. Some farmers filled out digital forms at the event. Paper-based responses were input into KoBoToolbox for data compilation. The information sheet and survey were made available in both English and Welsh in both paper and digital form, and participants could respond in either language. The Welsh language responses were translated into English before interpretation of the data. Data were collected on (i) the incidence of presumed HypoMgT (PHT); (ii) ways used to treat HypoMgT; (iii) mineral testing conducted on animals, forage or soil; and (iv) farm type and herd or flock size.
Fig 1

Number of respondents by district.

Geographical distribution of cattle and sheep farmers that participated in the survey. Number of respondents presented by district to protect individual farm identity.

Number of respondents by district.

Geographical distribution of cattle and sheep farmers that participated in the survey. Number of respondents presented by district to protect individual farm identity. Data cleaning was carried out in Microsoft Excel 2016. Thirteen questionnaire responses were excluded where the number of cattle was <11, the number of sheep was <26, and where there were contradictory responses. Statistical analysis was conducted using IBM SPSS 25. Pearson’s chi square test was used to check the association between incidence of PHT, mineral testing and use of treatments against HypoMgT. Farms were grouped into beef, dairy and sheep farm enterprise and combinations to assess if there was variation among enterprise types with regards to incidence of HypoMgT, mineral tests and treatments to control HypoMgT, where there were 30 or more respondents from a farm enterprise group. Euler diagrams were drawn using an online tool at http://bioinformatics.psb.ugent.be/webtools/Venn/. Map was produced using ArcMap 10.7. Other visualisations were produced using Tableau Desktop (Professional Edition 2019.2).

Results

A total of 285 useable responses were received from Wales (51%), England (35%), Scotland (11%) and Northern Ireland (3%). When considered by ruminant enterprise (i.e., beef, dairy and sheep), 45% of the respondents had mixed beef and sheep enterprises, 13% had dairy only and 16% had sheep only enterprises. The remaining ~26% of the respondents were beef only, mixed beef-dairy, mixed beef-dairy-sheep, and mixed dairy-sheep enterprises, with the number of respondents in each category and combination less than 30 farms (Fig 2). Compared to the nationally representative Farm Business Survey [16], this survey’s respondents were skewed towards beef and sheep farmers, although this also reflects the geographic location of participants in the west of Britain where most beef and sheep production is concentrated [17].
Fig 2

Survey respondents by farm enterprise and combinations.

(A) Number of beef, dairy, and sheep farms and their combinations in the current survey, n = 285. (B) Number of beef, dairy, and sheep farms in the 2012/13 farm business survey, n = 455.

Survey respondents by farm enterprise and combinations.

(A) Number of beef, dairy, and sheep farms and their combinations in the current survey, n = 285. (B) Number of beef, dairy, and sheep farms in the 2012/13 farm business survey, n = 455.

Prevalence of hypomagnesaemic tetany (HypoMgT)

Out of 285 respondents, 110 farmers (39%) stated their livestock had been affected by HypoMgT at some point (Fig 3b). By farm enterprise, 47% of mixed beef and sheep, 33% of sheep and 32% of dairy farm participants reported incidence of HypoMgT in their livestock affecting 1 to 30 animals in a given year (Fig 3a). There was no significant association between the prevalence of PHT and farm enterprise types (n = 285, χ2 = 8.1, degrees of freedom [d.f.] = 6, p = 0.2).
Fig 3

Incidence of presumed hypomagnesaemic tetany (PHT).

(A) Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that reported incidence (yes) or no incidence (no) PHT. (B) Overall percentage incidence of PHT.

Incidence of presumed hypomagnesaemic tetany (PHT).

(A) Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that reported incidence (yes) or no incidence (no) PHT. (B) Overall percentage incidence of PHT.

Interventions to tackle hypomagnesaemic tetany (HypoMgT)

Irrespective of the incidence of presumed HypoMgT (PHT), 84% of the respondents had used preventative and/or treatment measures against HypoMgT (Fig 4b and 4c). These interventions were categorised into in-feed, in-water, free access supplements (licks, blocks and buckets), direct (boluses, drenches and injections), pasture dressing (e.g., Mg lime/fertiliser), management changes (e.g., avoiding certain fields at certain times), a generic mineral supplementation (route of supplementation not indicated but likely to be either in feed, free access or direct) or nothing (Tables 1 and 2). A total of 308 intervention categories were reported by the 226 participants who did something and the most common intervention reported was use of free access minerals (n = 149; 62% of the number of respondent who carried out a treat/prevent strategy). The next most common interventions were in feed strategies (n = 59, 25%) and direct to animal strategies (n = 45, 19%) with all others categories having n<25. There were 10 farms which stated prevention/treatment strategies, which would not address a Mg issue: generally direct-to-animal trace element supplements that do not contain Mg. Only 3% (n = 9) of the respondents reported the use of Mg-lime to correct underlying available soil Mg-deficiencies. Out of the 110 farmers who reported incidence of HypoMgT, 96% reported using treatment/prevention interventions to abate it (Fig 4a and 4d). Similarly, out of the 175 farmers that reported no incidence of HypoMgT in their livestock, 76% had used similar range of interventions as preventative and/or treatment measures (Fig 4e). Overall, 42 farms without PHT and 4 farms with PHT did not use any HypoMgT intervention. There was an overall highly significant association between the use of interventions to tackle HypoMgT and the incidence of PHT (Table 3) with variation among farm enterprises. In the dairy enterprises, there was no significant association between incidence of PHT and use of intervention. In the sheep farming enterprises, the association was marginal (Table 3).
Fig 4

Use of interventions to tackle hypomagnesaemic tetany (HypoMgT).

Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that used (Yes) or did not use (No) Mg treatment measures to tackle hypomagnesaemic tetany (HypoMgT) (A) with (Yes) and without (No) the incidence presumed HypoMgT (PHT) and (B) regardless of the incidence of PHT. (C) Overall percent usage of interventions regardless of presumed hypomagnesaemic tetany (PHT) incidence, (D) with PHT incidence and (E) without PHT incidence.

Table 1

The distribution of interventions used, according to species and incidence of presumed hypomagnesaemic tetany (PHT).

FarmPHTIn feedFree accessGenericIn waterDirectPastureManagementNothing
CattleAll2725513102219
No18153631117
Yes910277112
Cattle and sheepAll26100610276622
No164955105120
Yes10511517152
SheepAll624118125
No4141325
Yes210151
Grand total5914912244591046
Table 2

Number of farms that used various interventions to prevent/treat hypomagnesaemic tetany (HypoMgT) by categories for the different species and incidence of presumed HypoMgT (PHT).

Interventions (n)PHTCattleCattle and SheepSheep
NoneYes220
No17205
OneYes14466 *
No2848 *15
TwoYes916 *4
No819 *2 *
Three or moreYes232
No121

* Two further interventions which were inappropriate to treat/prevent HypoMgT. Total n = 285, cattle n = 82, cattle and sheep n = 157, sheep n = 46.

Table 3

Fisher’s exact test of association among the use of interventions to prevent/treat hypomagnesaemic tetany (HypoMgT), incidence of presumed HypoMgT (PHT) and farm enterprises.

Farm enterprisenExact significance (2-sided)
Beef-sheep1270.005
Dairy380.147
Sheep460.078
Total2110.000

Use of interventions to tackle hypomagnesaemic tetany (HypoMgT).

Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that used (Yes) or did not use (No) Mg treatment measures to tackle hypomagnesaemic tetany (HypoMgT) (A) with (Yes) and without (No) the incidence presumed HypoMgT (PHT) and (B) regardless of the incidence of PHT. (C) Overall percent usage of interventions regardless of presumed hypomagnesaemic tetany (PHT) incidence, (D) with PHT incidence and (E) without PHT incidence. * Two further interventions which were inappropriate to treat/prevent HypoMgT. Total n = 285, cattle n = 82, cattle and sheep n = 157, sheep n = 46.

Animal, forage and soil mineral testing

Overall, 24%, 53% and 66% of all the respondents reported mineral testing on animal, forage, and soil, respectively (Fig 5g–5i). Small proportional differences occurred where PHT was reported, 25%, 54%, and 65%, and was not reported, 22%, 53% and 67%, for animal, forage and soil mineral tests, respectively (Fig 6b). Soil mineral tests were reported by 59%, 65% and 68% of the sheep, mixed beef and sheep, and dairy farm respondents, respectively (Fig 7f) whilst 24%, 50% and 68%, of the same enterprise types used forage mineral tests (Fig 7e). Direct testing of livestock was used at 24%, 21% and 24%, of the sheep, mixed beef and sheep, and dairy farms, respectively (Fig 7d). Overall, 64 respondents reported using no mineral testing at all (Fig 6).
Fig 5

Mineral testing by farm enterprise and incidence of presumed hypomagnesaemic tetany (PHT).

Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that conducted (Yes) or did not conduct (No) mineral tests on: (A) animal, (B) forage and (C) soil with and without the incidence of presumed hypomagnesaemic tetany (PHT). Percentage of farm enterprises that conducted (Yes) and did not conduct (No) mineral tests on: (D) animal, (E) forage and (F) soil regardless of the incidence of PHT. Overall percentage of farms that conducted (Yes) and did not conduct (No) mineral tests on: (G) animal, (H) forage and (I) soil.

Fig 6

Number of cattle and sheep farms that conducted mineral tests on animal, forage and soil.

(A) Overall. Those not testing = 65. (B) Farms reporting hypomagnesaemic tetany (HypoMgT). Those not testing = 23. (C) Farms reporting no HypoMgT. Those not testing = 42. Total n = 285.

Fig 7

Number of farms that conducted mineral tests on animal, forage and soil regardless of incidence of hypomagnesaemic tetany.

(A) Dairy farms, those that did not do neither test = 5. (B) Sheep farms, those that did not do neither test = 15. (C) Mixed beef and sheep farms, those that did not do neither test = 31 (c).

Mineral testing by farm enterprise and incidence of presumed hypomagnesaemic tetany (PHT).

Percentage of beef (B), mixed beef-dairy (BD), mixed beef-dairy-sheep (BDS), mixed beef-sheep (BS), dairy (D), mixed dairy-sheep (DS), and sheep (S) farms that conducted (Yes) or did not conduct (No) mineral tests on: (A) animal, (B) forage and (C) soil with and without the incidence of presumed hypomagnesaemic tetany (PHT). Percentage of farm enterprises that conducted (Yes) and did not conduct (No) mineral tests on: (D) animal, (E) forage and (F) soil regardless of the incidence of PHT. Overall percentage of farms that conducted (Yes) and did not conduct (No) mineral tests on: (G) animal, (H) forage and (I) soil.

Number of cattle and sheep farms that conducted mineral tests on animal, forage and soil.

(A) Overall. Those not testing = 65. (B) Farms reporting hypomagnesaemic tetany (HypoMgT). Those not testing = 23. (C) Farms reporting no HypoMgT. Those not testing = 42. Total n = 285.

Number of farms that conducted mineral tests on animal, forage and soil regardless of incidence of hypomagnesaemic tetany.

(A) Dairy farms, those that did not do neither test = 5. (B) Sheep farms, those that did not do neither test = 15. (C) Mixed beef and sheep farms, those that did not do neither test = 31 (c). Mineral testing on animals, forage and soil was independent of the incidence of PHT (Table 4). Forage mineral testing was conducted proportionally more by respondents with dairy and dairy-mixed enterprises compared to the other enterprises (Fig 5b and 5e). When there was no incidence of PHT, 65–82% of the dairy and mixed-dairy farms compared to 16–57% of the beef and /or sheep farms conducted mineral testing on forages. With the incidence of PHT, 67–100% of the dairy and mixed-dairy farms compared with 40–43% of the beef and/or sheep farms carried out mineral tests on forages (Fig 5b). Among the sheep farmers, 40% of the respondents with PHT conducted forage mineral tests compared to 16% of the farmers who reported no PHT (Fig 5b).
Table 4

Fisher’s exact test of association among mineral testing, incidence of presumed hypomagnesaemic tetany (PHT) and farm enterprises.

Farm enterprisenExact significance (2-sided)
AnimalForageSoil
Beef-sheep1271.0000.1570.852
Dairy380.2320.7140.486
Sheep460.0740.1371.000
Total2110.7420.8890.561

Discussion

The aim of this study was to determine the awareness of ruminant Mg deficiency among UK farmers. Due to the nature of recruitment, the results may not be representative of the wider grazing ruminant industry as participant selection for this study was carried out following a convenience sampling approach, rather than through a representative survey. Thus, the proportions reported should not be taken as representative of the grazing sector as a whole, or of the specific farm enterprise types included. It is likely that the farmers who participated in the current survey were particularly engaged, for example, seeking scientific and business information at agricultural events and/or shows to improve their livestock health, productivity and management. Presumed hypomagnesaemic tetany (PHT) was reported by 39% of the 285 cattle and sheep farmers who participated in this survey. This is greater than found by Roderick et al. [11] who reported 19% of dairy farms (n = 23), and 23% of suckler beef farms (n = 89) had presumed grass tetany under an organic livestock farming system in the UK. Equivalent information is not captured in any UK farm censuses, and official reporting is known to be low due to the widespread use of on-farm, non-veterinary diagnosis [18]. Our data indicate this problem may be affecting a small proportion of animals across a high proportion of farms. Further investigation is needed to establish if this remains the case with a representative survey and whether sub-clinical occurrence is being noticed by livestock managers. The prevalence of PHT was highest, at 55%, in mixed beef and sheep farms (n = 127) compared with 14% in sheep only farms (n = 46) in this survey. Further research is required to understand whether the higher prevalence of PHT in mixed livestock farm enterprises is due to factors such as the location of respondents, or is particular to the management systems being employed. The prevalence of PHT in dairy farm enterprises in this study (32%, n = 38) was higher than the 1982 report by Whitaker and Kelly [19], where an overall average incidence of 1% of clinical hypomagnesaemia in dairy farms, and 7% and 15% (n = 206) subclinical hypomagnesaemia in milking and dry dairy cows, respectively in England and Wales [19]. Unsurprisingly, the vast majority (96%) of farmers with PHT problems reported using an intervention, however, is noticeable that these were mainly free access and/or direct to animal supplements e.g., mineral blocks, boluses and salt licks. Only 3% (n = 9) of the respondents reported use of Mg-lime to correct underlying soil problems that may result in PHT. Other prevention measures such as pasture Mg-fertilisation, were not identified by participants. We did not capture whether animals survived the reported PHT, or were identified through diagnostics prior to visible symptoms. It is also noteworthy that 10 respondents reported use of an intervention which did not contain Mg, these were predominantly direct to animal trace element supplements (boluses, injections and drenches). This may be indicative of a misunderstanding that “mineral supplements” will contain the required micronutrient (here Mg), without further checking of the supplement composition. Use of mineral tests on soil, forage or livestock were reported by 77% of participants. Testing was unrelated to the reported incidence of PHT. Soil tests were conducted by most participants (66%), whilst direct livestock measurements (e.g. blood/urine biomarker) were conducted by 24%. Although biomarker measurement increases animal handling time and can cause stress for the livestock, this may be a better way of detecting deficiencies of Mg than soil and forage tests, especially where urine data are used [13]. Hypomagnesaemic tetany in grazing ruminants is dependent not only on the quantity of Mg in the forage, but also the balance with herbage K, Ca, Na, ammonia, and rumen pH [2, 3, 20–22]. The forage tetany index (Eq 1), is often used as a forage mineral balance quality indicator [23], demonstrating the further potential value of forage analysis, which was only reported by 53% of respondents. Noteworthy in this study is that the majority of dairy businesses reporting use of forage analysis had PHT. It is known that high K loading due to fertilisation of grazing pasturelands increases the risk of HypoMgT [24] and the current recommendation is to avoid using K fertilisers prior to turning livestock out in spring [25]. Opportunities to improve sward Mg-nutritional quality through breeding [26, 27] and pasture fertilisation or liming with Mg-lime may exist. Where, the elemental concentration (g kg-1 dry weight) is divided by the atomic weight and multiplied by the valence of the respective element. Index values are available for many soil properties, guiding pasture management decisions [25]. The majority of respondents in this study were from Wales and England (86%) where soil plant-available Mg concentrations are generally greater than the Index 2 (51 mg L-1) which is used as a Mg-fertiliser recommendation threshold [28, 29]. It is noteworthy that grassland soils are often not optimally managed for pH, with 53% being below the recommended value of 6.0 in a recent private sector data synthesis [29]. This is consistent with our finding that approximately one in five participating farms were not using any diagnostic mineral tests, and 34% were not conducting soil mineral test, which could be compromising their ability to optimally manage pasture. Further work is needed to understand the relationship between the pasture soil Mg index value, variation in herbage Mg and the forage tetany index, and the occurrence of clinical and sub-clinical hypomagnesaemia. Interestingly, lower rates of Mg-deficiency, at 2%, (measured using a serum Mg) in Northern Ireland [10] may reflect the large swathe of the land area being underlain by Mg containing rocks, and thus soil naturally enriched with Mg [30]. Results from this study indicate that Mg deficiency is more widespread in UK grazing ruminant farms than reported previously. Mineral nutrition is influenced by a wide variety of factors, including composition of soils and forages, pasture management especially soil pH and nutrient management, the use of feeds/supplements, the type of livestock, as well as flock/herd wider health and physiological conditions. Further research to quantify the prevalence of clinical Mg deficiency, and to understand sustainable and effective mitigation measures, would be of benefit to grazing ruminant enterprises in the UK and elsewhere.

Practical implications

The main implication of this work to the farmer is that they need to gather data on Mg in their pasture-livestock systems and undertake a dietary mineral audit [31]. The use of soil and forage mineral testing is more common than animal mineral testing, but none were universally used by the participants. It is clear that further information is needed on these inputs if hypomagnesaemic tetany (HypoMgT) risks are to be managed most effectively. In addition to Mg intake from forage, the intake from other sources also needs to be considered, which includes other feeds, supplements and water, and are covered in the full mineral audit process [31]. Care needs to be taken to ensure that supplements used are suitable to deliver the desired benefit. It may also be useful to assess the Mg status of the animal itself. Blood Mg is under tight homeostatic regulation and concentrations in serum/plasma will only decrease under extreme deficiency conditions. Urine Mg concentration is potentially a better indicator of an animal’s Mg status and collection of urine can be less intrusive. During the mineral audit, it is also important to look at potential interacting elements, particularly K, which can reduce Mg absorption in the gut, and hence increase the incidence of HypoMgT. Soil Mg treatments are not widely used but could be part of strategies to reduce HypoMgT. However, balanced forage composition is important and farmers need to be aware of the unintended consequences of using large quantities of K-containing fertilisers and farm yard manure for forage growth, which can then inhibit Mg absorption. Whilst this paper has focused on Mg, many of these practical implications are expected to be relevant to a range of mineral micronutrients.

Conclusion

More integrated soil-forage-animal assessments may improve the effectiveness of tackling hypomagnesaemic tetany, help highlight the root causes of the problem, and be used to guide optimal remediation/prevention strategies.

Semi-structured questionnaire and information sheet for interviewees.

(PDF) Click here for additional data file.

UK cattle and sheep farmers’ responses with regards to hypomagnesaemic tetany.

“OriginalData” worksheet is the uncleaned version of the data. “CleanedData” worksheet is the cleaned data used for the analyses in this manuscript. (XLSX) Click here for additional data file. 12 Jul 2019 PONE-D-19-17536 A reconnaissance survey of farmers’ awareness of hypomagnesaemic tetany in UK cattle and sheep farms PLOS ONE Dear Dr Kumssa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Aug 26 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Simon Russell Clegg, PhD Academic Editor PLOS ONE Journal Requirements: 1.  When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating the following in the Financial Disclosure section: This work was supported by the Biotechnology and Biological Sciences Research Council (grant numbers BB/N004280/1 [ELA], BB/N004302/1 [MRB], BB/N004272/1 [AL]) and the Natural Environment Research Council, through the jointly funded initiative Sustainable Agriculture Research and Innovation Club (SARIC). The project is entitled Magnesium Network (MAG‐NET): Integrating Soil-Crop‐Animal Pathways to Improve Ruminant Health. https://gtr.ukri.org/projects?ref=BB%2FN004302%2F1 We note that one or more of the authors are employed by a commercial company: Livestock and Grassland Mineral Consultancy Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests Additional Editor Comments: Many thanks for submitting your manuscript to PLOS One Your manuscript was reviewed by two reviewers (finding expert reviewers in this area is difficult, but we managed to find two). One recommended to reject the manuscript and the other recommended a major revision. As this is a clear gap in knowledge and current research, I have recommended a major revision It would be most helpful if you could respond to each individual comment, and modify the manuscript appropriately. Wishing you the best of luck with the manuscript modifications Thanks Simon [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting topic, but the survey presented is very high level and simplistic. The questions were not tested or validated prior to use. The sample is not described as being representative of any major industry and geographic region. There is no discussion of how many surveys were distributed or the response rate. The statistical analysis of the main study questions does not account for the potential for confounding by enterprise type. Where associations are examined, only p values are reported. There are no measures of association or 95%CI. In the results, the authors jump between reporting percentages with and without a decimal place. Please be consistent. There also needs to be a clear numerator and denominator in each case or reference to a table with that information. The number of figures needs to be reduced dramatically as most do not add any information to the manuscript and could be captured adequately in the text or tables. The discussion starts with some of the study limitations and does not make a convincing case for what this paper adds to the literature. Sward composition is mentioned in the abstract but not in the main results of the paper. Reviewer #2: The results of the current study about hypomagnesemia have been obtained by a questionnaire with the usual limitations of such an approach. There are some recommendations. 1. Please integrate previous data about this topic from UK: Whitaker and Kelly (1982) Vet. Rec. 110, 450-451 and Wards and Parker (1999) Br. Soc. Anim. Sci. 24, 21-26. 2. The data from farms without hypomagnesemia should be omitted. These results are without primary interest. It could be mentioned very briefly in the discussion. Please focus on the results with hypomagnesemia. It appears to me that hypomagnesemia in dairy cattle is not the major problem at the present time. 3. Please restrict the discussion on epidemiology. Possible causes of hypomagnesemia should be reduced, because no available results of the current study can be presented. 4. I am missing a conclusion and a perspective for future research. Does it make sense to initiate corresponding measurements to confirm the data? 5. Why so many authors for a questionnaire? 6. Page 3 – line 52: Reference 5: Related to hypocalcaemia? Correct? 7. Page 4 – line 78: Underwood (number?) 8. Page 8 – table 2: * is not clear for me. What does it mean? 9. Page 11 – Equation 1: The equation should be explained with corresponding values. Where are the risks? 10. Page 11 – line 289: Kuusela et al.: not in the list of references 11. I am missing a paragraph about a relation of the own data with data from the literature. What is really knew? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. 16 Aug 2019 A rebuttal letter (response to editor and reviewers) is uploaded. 19 Sep 2019 PONE-D-19-17536R1 A reconnaissance survey of farmers’ awareness of hypomagnesaemic tetany in UK cattle and sheep farms PLOS ONE Dear Dr Kumssa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Many thanks for resubmitting your manuscript to PLOS One It has been reviewed by one of same reviewers as previously, and a new reviewer who made some very minor suggestions, (mainly typos and grammatical errors). Both reviewers also suggest the addition of a small conclusion, and some advice for farmers. If you could make the minor changes, and add in a small advice section and conclusion that will be great. I would be grateful if you could make these small changes and resubmit it. Please do not worry about a rebuttal to the minor typo/ grammatical reviewers comments, they are so minor that just a line saying all comments were actions will be more than enough. I will then recommend it for acceptance and publication without a need for re-review Many thanks Simon ============================== We would appreciate receiving your revised manuscript by Nov 03 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript: A very brief rebuttal letter that responds to the conclusion and advice section of the reviewer comments. The typos etc can just be a single line which says 'these were all actioned'. This letter should be uploaded as separate file and labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Simon Russell Clegg, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: I am still missing conclusions about future research according the present results. What should or can be done? Are there any advices for the farmers? Reviewer #3: This is a very interesting manuscript regarding an issue which we do see on farms around the UK and further afield, but rarely. It is very nice to see some new research and literature in the area. As I have only been asked to review a revised version, I have a few comments but all are very minor (typos, grammatical etc), as I felt the manuscript was very good and well written. I commend you on that and wish you the best of luck with future research. I will keep an eye out for more work from your group. Line 32- There was a highly significant Line 55- although you define MypoMgT in the abstract, it would also be useful to define it early in the introduction as well, as some people (like me) don’t read the abstract until the end. Line 61- same is true for defining PHT Line 65- this is a little unclear, I do wonder if it is meant to read as hypomagnesaemia related conditions were seen in 1-4% of cows …. Line 70-71- again unclear. I think it should read where magnesium, usually as part of a mineral premix, …. Line 82- would the reference not be better written as Roderick et al., ? Line 103- Should read- Prior to completing the survey, farmers were presented with an information sheet…… Line 108- Should read - English and Welsh, in both paper and digital form, and participants…. There is a stray ‘o’ in line 170- not sure what that should be Line 174 – maybe should read as …’76% had used a similar range…’ Line 265 would the reference not be better written as Roderick et al., ? Line 274. Sentence break needed …. In this survey. Further research …. Line 278, comma after the reference may help flow Line 288, a comma after ‘did not contain Mg,’ may aid flow Line 307- systems may read better I would also like to see a small paragraph as a bit of advice to farmers. As this is a relatively unresearched area, I think a bit of advice to farmers would be most beneficial But overall it is a very well written manuscript, which I do not need to review again if all comments are addressed. With very best wishes for the future ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. 25 Sep 2019 Response to reviewers document has been uploaded. Submitted filename: Response to reviewers.docx Click here for additional data file. 1 Oct 2019 A reconnaissance survey of farmers’ awareness of hypomagnesaemic tetany in UK cattle and sheep farms PONE-D-19-17536R2 Dear Dr. Kumssa We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Simon Russell Clegg, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Many thanks for resubmitting your manuscript to PLOS One and making the changes which were suggested I am very grateful for your efforts, and I have recommended your manuscript for publication I want to take this opportunity to thank you for your efforts and wish you the best of luck for your future research Many thanks Simon Reviewers' comments: 4 Oct 2019 PONE-D-19-17536R2 A reconnaissance survey of farmers’ awareness of hypomagnesaemic tetany in UK cattle and sheep farms Dear Dr. Kumssa: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Simon Russell Clegg Academic Editor PLOS ONE
  8 in total

Review 1.  Pathophysiology of grass tetany and other hypomagnesemias. Implications for clinical management.

Authors:  H Martens; M Schweigel
Journal:  Vet Clin North Am Food Anim Pract       Date:  2000-07       Impact factor: 3.357

2.  On farm factors increasing dark cutting in pasture finished beef cattle.

Authors:  K M W Loudon; I J Lean; D W Pethick; G E Gardner; L J Grubb; A C Evans; P McGilchrist
Journal:  Meat Sci       Date:  2018-06-21       Impact factor: 5.209

Review 3.  Using plant breeding and genetics to overcome the incidence of grass tetany.

Authors:  D A Sleper; K P Vogel; K H Asay; H F Mayland
Journal:  J Anim Sci       Date:  1989-12       Impact factor: 3.159

Review 4.  Magnesium homeostasis in cattle: absorption and excretion.

Authors:  Holger Martens; Sabine Leonhard-Marek; Monika Röntgen; Friederike Stumpff
Journal:  Nutr Res Rev       Date:  2018-01-10       Impact factor: 7.800

5.  Incidence of clinical and subclinical hypomagnesaemia in dairy cows in England and Wales.

Authors:  D A Whitaker; J M Kelly
Journal:  Vet Rec       Date:  1982-05-08       Impact factor: 2.695

6.  Incidence of bovine hypomagnesaemia in Northern Ireland and methods of magnesium supplementation.

Authors:  M A McCoy; E A Goodall; D G Kennedy
Journal:  Vet Rec       Date:  1996-01-13       Impact factor: 2.695

7.  Effect of reactivity rate and particle size of magnesium oxide on magnesium availability, acid-base balance, mineral metabolism, and milking performance of dairy cows.

Authors:  Z Xin; W B Tucker; R W Hemken
Journal:  J Dairy Sci       Date:  1989-02       Impact factor: 4.034

8.  Combining two national-scale datasets to map soil properties, the case of available magnesium in England and Wales.

Authors:  R M Lark; E L Ander; M R Broadley
Journal:  Eur J Soil Sci       Date:  2018-11-23       Impact factor: 4.949

  8 in total
  2 in total

1.  A spatial analysis of lime resources and their potential for improving soil magnesium concentrations and pH in grassland areas of England and Wales.

Authors:  T Bide; E L Ander; M R Broadley
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.996

2.  Magnesium and calcium overaccumulate in the leaves of a schengen3 mutant of Brassica rapa.

Authors:  Thomas D Alcock; Catherine L Thomas; Seosamh Ó Lochlainn; Paula Pongrac; Michael Wilson; Christopher Moore; Guilhem Reyt; Katarina Vogel-Mikuš; Mitja Kelemen; Rory Hayden; Lolita Wilson; Pauline Stephenson; Lars Østergaard; Judith A Irwin; John P Hammond; Graham J King; David E Salt; Neil S Graham; Philip J White; Martin R Broadley
Journal:  Plant Physiol       Date:  2021-07-06       Impact factor: 8.340

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.